ArticleThe Journal of clinical endocrinology and metabolism2022
Correction to: Lenvatinib Targets PDGFR-β Pericytes and Inhibits Synergy With Thyroid Carcinoma Cells: Novel Translational Insights.
PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.